N,N'-Disalicylalethylenediamine

N,N'-Disalicylalethylenediamine

SCHEMBL1123492

Oc1ccccc1C=NCCN=Cc1ccccc1O.[Co]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 8/20 0.96
CA2 P00918 7/20 0.96
KDM4E B2RXH2 2/20 0.96
CA9 Q16790 6/20 0.81
CA1 P00915 1/20 0.55
SIRT2 Q8IXJ6 1/20 0.55
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 1/20 0.49
THRB P10828 1/20 0.49
ALOX15 P16050 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CTRC Q99895 1/20 0.48
DUSP3 P51452 1/20 0.48
PTPN5 P54829 1/20 0.48
PTPN11 Q06124 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N,N'-Disalicylalethylenediamine SCHEMBL187357 1.00 CA12 (0.96) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL29441822 1.00 CA12 (0.96) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL22229 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL711494 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL247862 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL29356999 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL4290399 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL11613427 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL18852430 0.98 CA12 (1.00) CA12CA2KDM4ECA9CA1
N,N'-Disalicylalethylenediamine SCHEMBL25402948 0.96 CA12 (0.96) CA12CA2KDM4ECA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12580006-B2 Oxygen partial pressure regulation by use of organic oxygen-buffering materials such as transition metal salens in hermetically sealed electronic devices environment and related assemblies and methods WESTERN DIGITAL TECHNOLOGIES, INC. (US) 2026-03-17 US claimed
US-20260004818-A1 OXYGEN PARTIAL PRESSURE REGULATION BY USE OF ORGANIC OXYGEN-BUFFERING MATERIALS SUCH AS TRANSITION METAL SALENS IN HERMETICALLY SEALED ELECTRONIC DEVICES ENVIRONMENT AND RELATED ASSEMBLIES AND METHODS WESTERN DIGITAL TECH INC (US) 2026-01-01 US claimed
US-12214339-B2 Nanocage-confined catalyst, preparation process and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2025-02-04 US claimed
EP-3831478-B1 NANOCAGED CATALYST, PREPARATION METHOD, AND APPLICATION CHINA PETROLEUM & CHEM CORP (CN) 2024-11-27 EP claimed
US-20240375091-A1 EPOXYDATION CATALYST SYSTEMS AND PROCESS FOR PREPARING EPOXIDES COVESTRO DEUTSCHLAND AG (DE) 2024-11-14 US claimed
CN-118388317-B Method for preparing propylene glycol from propylene oxide 潍坊汇韬化工有限公司 2024-09-06 CN claimed
CN-118388317-A Method for preparing propylene glycol from propylene oxide 潍坊汇韬化工有限公司 2024-07-26 CN claimed
CN-118063463-A Preparation method of entecavir 苏州科技大学 2024-05-24 CN claimed
EP-4355482-A1 EPOXYDATION CATALYST SYSTEMS AND PROCESS FOR PREPARING EPOXIDES Covestro Deutschland AG (DE) 2024-04-24 EP claimed
CN-117529365-A Epoxidation catalyst system and process for preparing epoxide 科思创德国股份有限公司 2024-02-06 CN claimed
CN-109675629-B High-performance catalyst for preparing glycol by hydrating alkylene oxide, preparation method and application 中国石油化工股份有限公司 2022-04-05 CN claimed
CN-114195634-A Preparation method of 2-biphenylyl propionic acid compound 上海惠永药物研究有限公司 2022-03-18 CN claimed
US-20080050630-A1 Membrane-Electrode Assemblies for Fuel Cell, Their Manufacture and Use and Fuel Cells Incorporating Them ACTA S.P.A. (IT) 2008-02-28 US claimed
US-7253325-B2 Process for the preparation of alkylene glycols SAUDI BASIC INDUSTRIES CORPORATION (SA) 2007-08-07 US claimed
US-20070140955-A1 MICROCHANNEL WITH INTERNAL FIN SUPPORT FOR CATALYST OR SORPTION MEDIUM TONKOVICH ANNA L 2007-06-21 US claimed
US-7220390-B2 Microchannel with internal fin support for catalyst or sorption medium VELOCYS, INC. (US) 2007-05-22 US claimed
US-20070066856-A1 Process for the preparation of alkylene glycols SAUDI BASIC INDUSTRIES CORPORATION 2007-03-22 US claimed
US-20060069293-A1 Process for the preparation of alkylene glycols SAUDI BASIC INDUSTRIES CORPORATION 2006-03-30 US claimed
US-20040228781-A1 chemical reactors having microstructure passageways, catalysts supports, absorber materials and heat exchangers VELOCYS, INC. 2004-11-18 US claimed
US-6652627-B1 Process for separating a fluid component from a fluid mixture using microchannel process technology VELOCYS, INC. 2003-11-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240375091-A1 EPOXYDATION CATALYST SYSTEMS AND PROCESS FOR PREPARING EPOXIDES EPHX2, TET2, EPX CA12 1089/4885CA2 1210/4885KDM4E 693/4885
US-20070066856-A1 Process for the preparation of alkylene glycols PCNA, IDH1, POLN CA12 425/4885CA2 1693/4885KDM4E 702/4885
US-20260004818-A1 OXYGEN PARTIAL PRESSURE REGULATION BY USE OF ORGANIC OXYGEN-BUFFERING MATERIALS SUCH AS TRANSITION METAL SALENS IN HERMETICALLY SEALED ELECTRONIC DEVICES ENVIRONMENT AND RELATED ASSEMBLIES AND METHODS SOD3, SOD1, HMOX2 CA12 1082/4885CA2 101/4885KDM4E 521/4885
US-12580006-B2 Oxygen partial pressure regulation by use of organic oxygen-buffering materials such as transition metal salens in hermetically sealed electronic devices environment and related assemblies and methods SOD3, SOD1, HMOX2 CA12 1082/4885CA2 101/4885KDM4E 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.